インタビュー Gilles Parmentier, Head of Global Research Chemicals and Specialties

Gilles Parmentier は、ペプチド分野で豊富な経験を持つベテランのセールス マネージャーです(Head of Global Research Chemicals and Specialties)。Gilles は、化粧用ペプチド、診断用ペプチド、研究用ペプチドなど、ペプチドに関する幅広い経験を持っています。

インタビュー記事の詳細は”リリース元を見る”をクリックしてください。(youtubeでインタビュー映像をご覧いただけます）

Gilles Parmentier is a seasoned Sales Manager with extensive experience in the field of peptides. Gilles has broad experience with peptides, such as cosmetic peptides, diagnostic peptides, and research peptides. Through his work, Gilles has helped countless companies to navigate the complex landscape of peptide-based products, while staying at the forefront of this rapidly-evolving field. We sat down with Gilles to learn more about his experience, his current role and and what drives him. So without further ado, let’s dive in and meet Gilles Parmentier.

First off, how long have you been working at Bachem, what is your background, and what is your current role?
“This is a long story for which I will try to make a short answer. I joined Bachem in June but I had already worked for Bachem from 2004 to 2019, so 15 years already. In the meantime, I had a 3-year break as Senior BDM for a French-Belgian CDMO (Contract development and manufacturing organization). I am a chemist by education. I completed my PhD in Strasbourg almost 30 years ago and my current role is in sales as Head of Global Research Chemicals and Specialties.”
省略
What is molecular hiving™?
“The Molecular Hiving™ technology is an innovation we use to produce shorter peptides without hazardous solvents and higher process controls. We need less washing and filtration steps compared to classic peptide synthesis. Using this technology the need of organic solvents can be reduced by up to 60%.”
「Molecular Hiving™ テクノロジーは、危険な溶媒や高度なプロセス制御なしで、より短いペプチドを製造に使用するためのイノベーションです。従来のペプチド合成と比較して、洗浄とろ過のステップが少なくて済みます。この技術を使用すると、有機溶媒の必要性を最大 60% 削減できます。」
What is your favourite peptide and why?
“XEP-018 is a cosmetic peptide ingredient. I followed the development of this peptide from the very early R&D phase until its commercialization. I was proud to be part of this success story"

• リリース情報を見る
• リリース元を見る